Small molecule orphan drugs: Balancing financial incentives and complex challenges
Small molecule orphan drugs: Balancing financial incentives and complex challenges
オーファンドラッグの上市を目指す企業にとって、承認申請までの道のりを成功裏に進めるには、臨床試験までのスピードとコストのバランスをうまく取ることが必要です。

Added Date:

2022-05-15

Filters:

Filter Category Filter Values
Specialty
  • Other
Month
  • January
Capability
  • Active Pharmaceutical Ingredient (API)
Year
  • 2022
Asset Type
  • Whitepaper
Region
  • Global
Market Category
  • Small molecule

Country Availability:


()

Gated Form:

None Set